BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32966423)

  • 1. CRISPR-Cas12a
    Li Y; Li T; Liu BF; Hu R; Zhu J; He T; Zhou X; Li C; Yang Y; Liu M
    Chem Commun (Camb); 2020 Oct; 56(83):12526-12529. PubMed ID: 32966423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-throughput in vitro detection of DNA cleavage by CRISPR-Cas12a.
    Creutzburg SCA; Swartjes T; van der Oost J
    Methods; 2020 Feb; 172():27-31. PubMed ID: 31726224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mg
    Son H; Park J; Hwang I; Jung Y; Bae S; Lee S
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets.
    Nalefski EA; Kooistra RM; Parikh I; Hedley S; Rajaraman K; Madan D
    Nucleic Acids Res; 2024 May; 52(8):4502-4522. PubMed ID: 38477377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into multistage inhibition of CRISPR-Cas12a by AcrVA4.
    Peng R; Li Z; Xu Y; He S; Peng Q; Wu LA; Wu Y; Qi J; Wang P; Shi Y; Gao GF
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):18928-18936. PubMed ID: 31467167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate-modified G-quadruplex as a signal-on dual-mode reporter for CRISPR/Cas12a-based portable detection of environmental pollutants.
    Shi K; Tian Y; Liu S; Luo W; Liu K; Zhang L; Zhang Y; Chang J; Zhang J; Wang S
    Anal Chim Acta; 2024 Jun; 1308():342649. PubMed ID: 38740457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lesinski JM; Moragues T; Mathur P; Shen Y; Paganini C; Bezinge L; Verberckmoes B; Van Eenooghe B; Stavrakis S; deMello AJ; Richards DA
    Anal Chem; 2024 Jun; 96(25):10443-10450. PubMed ID: 38864271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.
    Ageely EA; Chilamkurthy R; Jana S; Abdullahu L; O'Reilly D; Jensik PJ; Damha MJ; Gagnon KT
    Nat Commun; 2021 Nov; 12(1):6591. PubMed ID: 34782635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
    Yan F; Wang W; Zhang J
    Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas12a-Powered Amplification-Free RNA Diagnostics by Integrating T7 Exonuclease-Assisted Target Recycling and Split G-Quadruplex Catalytic Signal Output.
    Zhang D; Tian B; Ling Y; Ye L; Xiao M; Yuan K; Zhang X; Zheng G; Li X; Zheng J; Liao Y; Shu B; Gu B
    Anal Chem; 2024 Jun; 96(25):10451-10458. PubMed ID: 38860917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
    Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
    Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanics of CRISPR-Cas12a and engineered variants on λ-DNA.
    Paul B; Chaubet L; Verver DE; Montoya G
    Nucleic Acids Res; 2022 May; 50(9):5208-5225. PubMed ID: 34951457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed conditional genome editing with Cas12a in
    Port F; Starostecka M; Boutros M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks.
    Cofsky JC; Karandur D; Huang CJ; Witte IP; Kuriyan J; Doudna JA
    Elife; 2020 Jun; 9():. PubMed ID: 32519675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.